For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
Site Tools
Alzheimer's disease - Independent medicine & health information for consumers & professionals Alzheimer's disease
Show health professional infoLatest independent information about Alzheimer's disease, including medicines and non-drug treatments, written and reviewed by experts in Australia.
| Filter by audience: | |
|---|---|
| All | |
| Consumer | |
| Health professional | |
| Researchers & evaluators | |
| Members & stakeholders | |
| Other | |
| Title | Description | Type | Audience  |
Date* |
|---|---|---|---|---|
Antipsychotic medicines and dementia: a fine balancing act |
NPS is warning people about the use of antipsychotic medicines in people suffering behavioural or psychological problems associated with dementia. Studies show that using these medicines for longer than necessary, especially in the elderly, can lead to serious side effects that can be life-threatening |
Media release | Others | 2011-11-17 19:00:00 |
Case study 15 report: Focus on psychogeriatrics |
Patient requests the 'new Alzheimer's treatment' for her elderly mother who has severe Alzhemiers disease. |
Professional activity - Case study report | Health Professionals | 2001-09-01 00:00:00 |
Dementia survey |
Dementia survey |
Web page | Health Professionals | 2011-01-01 00:00:00 |
Articles on drugs for dementia & Alzheimer's Disease from NPS RADAR |
Get independent, evidence-based info on drugs for dementia & Alzheimer's Disease. Written for doctors, pharmacists & other health professionals. |
Topic overview | Health Professionals | 2009-10-28 00:00:00 |
Galantamine (Reminyl) prolonged-release capsules for dementia in Alzheimer's disease |
Reviews use of galantamine prolonged-release capsules for dementia in Alzheimer's disease, including comparison with immediate-release preparation and long-term therapeutic effect. |
Professional publication - NPS RADAR - Review | Health Professionals | 2004-12-01 00:00:00 |
New Alzheimer's drugs |
Reviews evidence on efficacy of donepezil and rivastigmine in Alzheimer's disease, including side effects, and on managing behavioural disturbances in dementia using complementary medicine. Includes case study. |
Professional publication - NPS News | Health Professionals | 2001-06-01 00:00:00 |
Dementia - Drug treatment |
Reviews non-drug treatments and drug treatments for dementia and Alzheimer’s disease, and when to consider stopping drug treatment. |
Professional publication - NPS News | Health Professionals | 2008-08-01 00:00:00 |
Information on this website is published by NPS — an independent, evidence based, not-for-profit organisation funded by the Australian Government Department of Health and Ageing.
NPS develops its information under the guidance of experts in their field, editorial panels, expert reviewers and consumers. Find out more about how we develop our content.
Date published: 2010-12-17 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.
